Related references
Note: Only part of the references are listed.How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine
John J. V. McMurray et al.
CIRCULATION (2021)
Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF
Pooja Dewan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)
Kevin Damman et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Cancer in chronic heart failure patients in the GISSI-HF trial
Pietro Ameri et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Trends in prevalence of comorbidities in heart failure clinical trials
Muhammad Shahzeb Khan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure The RECEDE-CHF Trial
Natalie A. Mordi et al.
CIRCULATION (2020)
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failure (an update on the sodium-glucose co-transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology)
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis
Giacomo Tini et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Design of a prospective patient-level pooled analysis of two parallel trials of empagliflozin in patients with established heart failure
Milton Packer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction
Massar Omar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors A State-of-the-Art Review
Gary D. Lopaschuk et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2020)
Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry
Constantinos Ergatoudes et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar M. Seferovic et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial
Milton Packer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Evaluation of the effects of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR-Preserved Trial
Stefan D. Anker et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
Marco Canepa et al.
JACC-HEART FAILURE (2019)
Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry
Marco Canepa et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial
Marco Canepa et al.
CARDIOLOGY (2017)
What can we learn from pulmonary function testing in heart failure?
Helgo Magnussen et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Treatment Evolution after COPD Diagnosis in the UK Primary Care Setting
Keele E. Wurst et al.
PLOS ONE (2014)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Share Paper
